Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

Recruiting

18 years and older

All

Phase N/A

Technical (Original)
Simplified (AI rewritten)

Powered by AI

Overview

This multicenter prospective observational study will evaluate the value of dynamic FDG-PET LAFOV imaging during the initial therapeutic assessment of a head and neck cancer 3 months after completion of curative radiotherapy.

Eligibility

Inclusion Criteria:

Adult patient ≥ 18 years of age
Presenting with head and neck squamous cell carcinoma
Completed curative treatment with external radiation therapy
Eligible for dynamic LAFOV FDG-PET scan for therapeutic evaluation at 3 months
Having given consent for the end-of-treatment consultation

Exclusion Criteria:

Hypersensitivity to 18F-FDG or other excipients contained in the contrast agent
Pregnancy or breastfeeding
History of treated upper gastrointestinal tract cancer
Other histology
Incomplete RTE treatment regimen
Refusal to participate

Study details

Conditions

Head & Neck Squamous Cell Carcinoma

Clinical Study Identifier

NCT07417605

Sponsor

University Hospital, Brest

Last Modified on

20 October 2026

Contact a study center

Step 1 Get in touch with the nearest study center

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

Other languages supported:

First name*

Last name*

Email*

Phone number*

Other language

I am at least 18 years old.

By sending a message, I agree to share my information with the study team for the selected site and consent to receive emails and text messages for trial updates, notifications, and related communication. TrialX values your privacy; your information will be handled in accordance with our Privacy Policy

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.

Study Definition

Wikipedia

One platform. Various ways to connect patients to your clinical studies.

From discovery to participation, our platform supports every step of the patient journey.

Get in touch with our team

TrialX is a clinical research and space health informatics company. From launching the first clinical trials app on Google Health in 2008, to powering online patient recruitment and research data collection for space missions, TrialX is empowering clinical research here on earth and beyond.

Menu

Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

Overview